MasterClass: Presynaptic Possibilities: The Past, Present, and Future of Modulating Dopamine

As our understanding of dopamine regulation evolves, new therapeutic strategies are expanding beyond traditional postsynaptic targets. This session examines the neurobiology of presynaptic dopamine modulation across schizophrenia and bipolar I mania, reviews emerging evidence for selective muscarinic agents, and provides practical guidance for applying these developments to individualized patient care.

Supported by an educational grant from Bristol-Myers Squibb.